Carea, a pregnancy and postnatal wellbeing app that prioritises women’s health, has launched the Postpartum Mum Tracker to support the 1 in 5 new mothers who face post-birth mental health struggles.
CAMBRIDGE, Mass., Nov. 18, 2025 /PRNewswire/ — Nanopath, a point-of-care diagnostics company enabling high-quality molecular testing in minutes, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company’s novel assay for the rapid detection of infection in patients with suspected, or at risk of, complicated urinary tract infections (UTIs).
A research team led by two University of Maine Ph.D. students developed an artificial intelligence (AI) system that could make it easier and faster for doctors to identify signs of breast cancer in tissue samples, possibly preventing delays and saving lives.
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers at UCL and UCLH.
A decade ago, at age 55, Don Lewis suffered a stroke in his sleep. When he woke up, he couldn’t move his left arm or leg. Lewis’s neighbor realized his truck hadn’t moved in two days and called 911 for a welfare check. When paramedics found him, he was paralyzed on one side.
A new study led by researchers from Murdoch University’s School of Psychology, Personalized Medicine Center, and Center for Healthy Aging, Health Futures Institute has found that heart rate variability biofeedback can significantly reduce symptoms of both PTSD and chronic pain—two conditions that frequently co-occur and are notoriously difficult to treat together.
A new study provides a powerful way to study infections in environments that closely mimic human organs.
Our body’s “blood factory” consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this cellular complexity in the laboratory using only human cells. The novel system could reduce the need for animal experiments for many applications.
1nhaler announced today that it secured approximately $2 million (£1.5 million) in seed funding to support its inhaler technology.
RALEIGH, N.C., Nov. 17, 2025 /PRNewswire/ — Arctx Medical, Inc. (“Arctx,” “the Company”), a clinical-stage medical device company, announced today that it has achieved two additional significant milestones: